Long COVID: Implications for Clinical Development

by Paul Oloo
18th February 2021 • 0 comments

A Comparison of Study Population Inclusion and Exclusion Criteria reported in Advanced Stage Clinical Trial Protocols

by Paul Oloo
19th November 2020 • 0 comments

CEPI welcomes announcement from Pfizer / BioNTech of positive interim data from Phase III trial of COVID-19 vaccine candidate

by CEPI

Pfizer and BioNTech have announced that their vaccine candidate against COVID-19 achieved success in the first interim analysis from the phase 3 COVID-19 vaccine trial.

10th November 2020 • 0 comments

A Comparison of Vaccine Efficacy Elements in Advanced Stage Clinical Trial Protocols

by Paul Oloo
9th November 2020 • 0 comments

Evaluating the Burden-of-Disease Endpoint to Assess Vaccine Efficacy

by Edde Loeliger and Bob Small
26th October 2020 • 0 comments

Workshop Report: COVAX Vaccine Safety Working Group: Developer Needs Workshop

by Dr Julia Granerod
21st October 2020 • 0 comments

COVID-19 Efficacy Endpoints in Interventional Trials: What Constitutes an Incident Clinical Disease Case and What Triggers Diagnostic Work-Up V2.0

by Edde Loeliger & Amol Chaudhari
20th October 2020 • 0 comments

CONSIDERATIONS FOR EVALUATION OF COVID19 VACCINES

by World Health Organization
30th September 2020 • 0 comments

COVID-19 Vaccines: Target Product Characteristics

by CEPI
16th September 2020 • 0 comments

Priority List of COVID-19 Adverse events of special interest: Quarterly update 1

by Barbara Law
9th September 2020 • 0 comments

Early and Advanced Stage Clinical Development Core Elements- Comparison of the Guidance and Considerations

by Paul Oloo
3rd September 2020 • 0 comments

Considerations for Inclusion of Risk Populations into COVID-19 Vaccine Efficacy Trials

by Paul Oloo & Edde Loeliger
17th July 2020 • 0 comments

CEPI workshop on Maternal Immunization against Emerging Infectious Diseases

by CEPI
1st July 2020 • 0 comments

Workshop Report - Launching Lassa fever epidemiology studies across West Africa

by Christine Berge & Eirik Torheim
1st July 2020 • 0 comments

Preparing for Lassa vaccine clinical trials with targeted epidemiology studies

by CEPI
1st July 2020 • 0 comments

Reporting of notifiable infectious diseases during the COVID-19 response

by Pawel Stefanoff et al.
1st July 2020 • 0 comments

Core Elements for Advanced Stage Clinical Trials of COVID-19 Vaccine Candidates: Aspects to Consider

by Amol Chaudhari
26th June 2020 • 0 comments

Efficacy Endpoints in COVID-19 Vaccine Trials: SARS-CoV-2 Infection

by Amol Chaudhari & Edde Loeliger
25th June 2020 • 0 comments

Vaccine Efficacy Assessment for COVID-19

by Edde Loeliger and Bob Small
7th May 2020 • 0 comments

General Core Elements for Early Phase Clinical Trials of COVID-19 Vaccine Candidates: Aspects to Consider

by Amol Chaudhari
21st April 2020 • 0 comments